Brenner Tumor - 50 Studies Found Estado Estudiar Recruiting Nombre del estudio: Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condición: Clear Cell Adenocarcinoma Fallopian Tube Clear Cell Adenocarcinoma Biological: Bevacizumab Given Active, not recruiting Nombre del estudio: Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Condición: Fallopian Tube Carcinosarcoma Fallopian Tube Clear Cell Adenocarcinoma Biological: Bevacizumab Given Completed Nombre del estudio: Collecting Tumor Samples From Patients With Gynecological Tumors Condición: Borderline Ovarian Clear Cell Tumor Borderline Ovarian Serous Tumor Chemotherapeutic Agent Toxicity Endometrial Adenocarcinoma Fecha: 2008-12-20 Intervenciones: Drug: Paclitaxel Given IV or i Completed Nombre del estudio: Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condición: Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Adenocarcinoma Fecha: 2005-12-06 Intervenciones: Biological: Bevacizumab Given Completed Nombre del estudio: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer Condición: Brenner Tumor Ovarian Clear Cell Cystadenocarcinoma Fecha: 1999-11-01 Intervenciones: Drug: paclitaxel Given IV Completed Nombre del estudio: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin Condición: Brenner Tumor Fallopian Tube Cancer Drug: belinostat Given IV Completed Nombre del estudio: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy Condición: Brenner Tumor Fallopian Tube Cancer Biological: sargramostim Given Completed Nombre del estudio: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma Condición: Brenner Tumor Fallopian Tube Cancer Drug: paclitaxel Given IV Recruiting Nombre del estudio: Metformin Hydrochloride and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condición: Brenner Tumor Malignant Ascites Drug: paclitaxel Given IV <<< Previous | Next >>>